Operating Cash Flow
Roivant Sciences Operating Cash Flow increased by 16.6% to -$163.82M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.1%, from -$172.57M to -$163.82M. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows a downward trend with a 2.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
Detailed definition
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Peer comparison
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operatingHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$141.17M | -$120.60M | -$268.49M | -$147.47M | -$252.08M | -$189.63M | -$222.59M | -$179.09M | -$249.93M | -$196.43M | -$210.45M | -$108.46M | -$192.83M | -$266.81M | -$207.25M | -$172.57M | -$204.38M | -$185.66M | -$196.48M | -$163.82M |
| QoQ Change | — | +14.6% | -122.6% | +45.1% | -70.9% | +24.8% | -17.4% | +19.5% | -39.6% | +21.4% | -7.1% | +48.5% | -77.8% | -38.4% | +22.3% | +16.7% | -18.4% | +9.2% | -5.8% | +16.6% |
| YoY Change | — | — | — | — | -78.6% | -57.2% | +17.1% | -21.4% | +0.9% | -3.6% | +5.5% | +39.4% | +22.8% | -35.8% | +1.5% | -59.1% | -6.0% | +30.4% | +5.2% | +5.1% |
Operating Cash Flow at Other Companies
Frequently Asked Questions
- What is Roivant Sciences's operating cash flow?
- Roivant Sciences (ROIV) reported operating cash flow of -$163.82M in Q1 2026.
- How has Roivant Sciences's operating cash flow changed year-over-year?
- Roivant Sciences's operating cash flow increased by 5.1% year-over-year, from -$172.57M to -$163.82M.
- What is the long-term trend for Roivant Sciences's operating cash flow?
- Over 4 years (2021 to 2025), Roivant Sciences's operating cash flow has grown at a 2.6% compound annual growth rate (CAGR), from -$677.73M to -$750.35M.
- What does operating cash flow mean?
- The amount of cash a company generates from its regular business activities.